PRE-CLINICAL STUDIES FOR ADVANCING CIRMTUZUMAB-BASED ANTI-ROR1 THERAPIES IN METASTATIC PROSTATE CANCER

被引：0
|
作者：
Muldong, Michelle
Lee, Sanghee
Mendoza, Theresa
Burner, Danielle
Wu, Christina
Murtadha, Jamillah
Koutouan, Evodie
Pineda, Naomi
Pineda, Gabriel
Lennon, Kathleen
Hao Pham
Willert, Karl
Cacalano, Nicholas
Jamieson, Catriona
Gaasterland, Terry
Kane, Christopher
Kulidjian, Anna
Jamieson, Christina
机构：
来源：
JOURNAL OF UROLOGY | 2022年 / 207卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
PD07-04
引用
收藏
页码：E99 / E99
页数：1
相关论文
共 50 条
  • [31] Pre-clinical evaluation of 1-nitroacridine derived chemotherapeutic agent that has preferential cytotoxic activity towards prostate cancer
    Tadi, Kiranmayi
    Ashok, Badithe T.
    Chen, Yuangen
    Banerjee, Debabrata
    Wysocka-Skrzela, Barbara
    Konopa, Jerzy
    Darzynkiewicz, Zbigniew
    Tiwari, Rai K.
    CANCER BIOLOGY & THERAPY, 2007, 6 (10) : 1632 - 1637
  • [32] Neutralizing anti-vascular endothelial growth factor antibody inhibits further growth of established prostate cancer and metastases in a pre-clinical model
    Melnyk, O
    Zimmerman, M
    Kim, KJ
    Shuman, M
    JOURNAL OF UROLOGY, 1999, 161 (03): : 960 - 963
  • [33] The 22Rv1 prostate cancer cell line carries mixed genetic ancestry: Implications for prostate cancer health disparities research using pre-clinical models
    Woods-Burnham, Leanne
    Basu, Anamika
    Cajigas-Du Ross, Christina K.
    Love, Arthur
    Yates, Clayton
    De Leon, Marino
    Roy, Sourav
    Casiano, Carlos A.
    PROSTATE, 2017, 77 (16): : 1601 - 1608
  • [34] Radiocobalt-labeled anti-HER1 affibody molecule DOTA-ZEGFR:2377 for imaging of low HER1 expression in prostate cancer pre-clinical model
    Mitran, B.
    Garousi, J.
    Rosestedt, M.
    Lindstrom, E.
    Andersson, K. G.
    Stahl, S.
    Lofblom, J.
    Tolmachev, V.
    Orlova, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2017, 44 : S145 - S145
  • [35] Gastrin-releasing peptide receptor agonists and antagonists for molecular imaging of breast and prostate cancer: from pre-clinical studies to translational perspectives
    Gorica, Joana
    De Feo, Maria Silvia
    Filippi, Luca
    Frantellizzi, Viviana
    Schillaci, Orazio
    De Vincentis, Giuseppe
    EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2022, 22 (11) : 991 - 996
  • [36] On the pre-clinical validation of a commercial model-based optimisation engine: Application to volumetric modulated arc therapy for patients with lung or prostate cancer
    Fogliata, Antonella
    Belosi, Francesca
    Clivio, Alessandro
    Navarria, Piera
    Nicolini, Giorgia
    Scorsetti, Marta
    Vanetti, Eugenio
    Cozzi, Luca
    RADIOTHERAPY AND ONCOLOGY, 2014, 113 (03) : 385 - 391
  • [37] Ipatasertib, an oral AKT inhibitor, exhibits anti-proliferative and anti-tumorigenic effects in pre-clinical studies for endometrioid endometrial cancer: Endometrial Cancer Molecularly Targeted Therapy Consortium
    O'Donnell, Jillian
    Buckingham, Lindsey
    Hao, Tianran
    Secord, Angeles Alvarez
    Zhou, Chunxiao
    Bae-Jump, Victoria
    GYNECOLOGIC ONCOLOGY, 2021, 162 : S41 - S42
  • [38] AGI-134, a fully synthetic α-Gal-based cancer immunotherapy: Synergy with an anti-PD-1 antibody and pre-clinical pharmacokinetic and toxicity profiles
    Kristian, Sascha A.
    Shaw, Stephen M.
    Wigglesworth, Kim
    Middleton, Jenny
    Glossop, Melanie S.
    Whalen, Giles Francis
    Old, Robert
    Galili, Uri
    Westby, Mike
    Pickford, Chris
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [39] A Pre-clinical Trial Study: Anti-human Colon Cancer Effect of Thalassiolin B in vitro with Enzymes Inhibition Effects and Molecular Docking Studies
    Li, Yanzhen
    Cheng, Ruhuan
    Zou, Shaojing
    Zhang, Yun
    Alotaibi, Saad H.
    Xu, Long
    JOURNAL OF OLEO SCIENCE, 2022, 71 (02) : 267 - 276
  • [40] Monitoring of anti-cancer treatment with F-18-FDG and F-18-FLT PET: a comprehensive review of pre-clinical studies
    Jensen, Mette Munk
    Kjaer, Andreas
    AMERICAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2015, 5 (05): : 431 - 456
12345